dactinomycin has been researched along with milnacipran in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, J; Shinkai, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N; Yoshimura, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for dactinomycin and milnacipran
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for dactinomycin and milnacipran
Article | Year |
---|---|
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells.
Topics: Adrenal Medulla; Adrenergic Uptake Inhibitors; Animals; Cattle; Cells, Cultured; Cycloheximide; Cyclopropanes; Dactinomycin; Desipramine; Gene Expression Regulation; Milnacipran; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; RNA, Messenger; Up-Regulation | 2005 |